Available Patents

CFD Research has developed innovative designs and methods which have culminated in a growing patent portfolio. Over 100 patents have been filed with the USPTO. Many of those patents have been licensed to other organizations.

Coupled multiphysics simulations facilitate objective filtering of ideas in all stages (concept -> design -> certification -> operation -> refurbishment) of products & system lifecycles. The most promising approaches are then prototyped, tested, and patented. Furthermore, many new developments are undertaken for specific customers, and in those cases Intellectual Property (IP) is shared, as appropriate, between the customer and CFD Research Corporation. The following patents are available for licensing and further development.

Drugs

• Compositions and Methods for Mitigating Aflatoxin B1-Induced Liver Injury; US Patent 11,364,239

Biomedical Devices

• “Nasal Flu Vaccination Device”; U.S. Patent 8,191,552
• Portable Platelet Apheresis System; U.S. Patent 12,318,524
• Self-Enclosed Bioreactor for Vascularized Tissue Constructs; U.S. Patent 12,545,873

Battery Technologies

• “Electrically Conductive Ink and Uses Thereof (Ink)”; U.S. Patent 8,685,286 and 9,994,725
• “Electrically Conductive Ink and Uses Thereof (Electrode)”; U.S. patent 8,703,022
• “Hematin Modified Biliruben Oxidase Cathode”; U.S. Patent 11,127,966 and 11,664,504
• “Alcohol Based Biofuel Cell”; U.S. Patent 11,139,500

Blast Exposure and Non-Lethal Weapons

• “System and Method for Reconstruction of Explosion Blast and Blast Loading on Humans Using Pressure Sensor Data”; U.S. Patent 10,983,202
• “System and Method for Model-Based Calculation and Recording of Blast Exposure on Humans during Military Training and Combat”; US Patent 11,145,418
• “Non-Lethal Weapons Modular Human Surrogate Testing Device and Method”, US Patent 11,600,203